KCT0005462
Completed
未知
Multicenter randomized controlled clinical trial comparing the volume stability of synthetic bone block and synthetic bone particulate in alveolar ridge preservation of severely damaged extraction socket
Yonsei University Health System, Dental Hospital0 sites60 target enrollmentTBD
ConditionsDiseases of the digestive system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the digestive system
- Sponsor
- Yonsei University Health System, Dental Hospital
- Enrollment
- 60
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Selection criteria
- •\-Adult men and women who are 18 years of age or older with periodontal health
- •\-Central incisors, lateral incisors, canines, 1st and 2nd in maxilla or mandible due to severe periodontal disease
- •Patients requiring extraction during premolar
- •\-Patients who are expected to observe vertical resorption of at least one of the buccal and lingual bone wall with the tooth extraction after extraction is equivalent to 1/2 or more of the root length of the tooth
- •\-Those who can comply with research procedures
- •\-Those with a signed consent form
Exclusion Criteria
- •2\) Exclusion criteria
- •Those who fall under any of the following
- •\-Vertical absorption of the buccal bone wall or lingual bone wall from the tooth after extraction is the root of the tooth
- •Patients expected to be observed by a height less than half the length
- •\-Bone wall that requires extraction due to severe periodontal disease, but shows severe vertical absorption
- •Patients whose mesial or distal side is not buccal or lingual
- •\-Patients with periodontal disease that is not controlled throughout the oral cavity
- •\-Patients with metabolic diseases such as uncontrolled diabetes
- •\-Patients with a history of receiving radiation therapy and chemotherapy in the head and neck area
- •\-Patients with a history of taking drugs that inhibit bone metabolism (Biosphosphonate or Denosumab series) within 4 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Multicenter randomized controlled clinical trial comparing ebastine and mebeverine as treatment of irritable bowel syndromeCTIS2022-501780-41-00Z Leuven200
Completed
Not Applicable
Multicenter randomized controlled clinical trial comparing immediate to delayed loading in dental implant treatment applying a full-digital workflowK00-K14Diseases of oral cavity, salivary glands and jawsDRKS00022286niversity of ZürichCenter of Dental MedicineClinic of Reconstructive Dentistry62
Recruiting
Not Applicable
Comparison of loading protocols under a full-digital workflowKCT0007935Zurich University62
Recruiting
Not Applicable
Multicenter randomized controlled clinical trial for therapeutic Evaluation of TCM in patients with extensive small cell lung cancer (SCLC)extensive small cell lung cancerITMCTR1900002318Beijing Hospital of TCM, Capital Medical University
Not yet recruiting
Not Applicable
Multicenter randomized controlled clinical trial of Tailin formulation combined with prolonged, low-dose antimicrobial therapy for recurrent urinary tract infectiorecurrent urinary tract infectionITMCTR2100004240Shanghai Municipal Hospital of Traditional Chinese Medicine